Ellomay Capital Reports Results for the Fourth Quarter and Full Year of 2019

31/03/2020 14:30

Source: PR News

TEL AVIV, Israel, March 31, 2020 /PRNewswire/ -- Ellomay Capital Ltd. (NYSE American: ELLO) (TASE: ELLO) ("Ellomay" or the "Company"), a renewable energy and power generator and developer of renewable energy and power projects in Europe and Israel, today reported its unaudited financial results for the fourth quarter and year ended December 31, 2019.

Financial Highlights

  • The Company recorded revenues of approximately €19 million for the year ended December 31, 2019, up 5% from approximately €18.1 million for the year ended December 31, 2018. The revenue increase is mainly due to the commencement of operations of the Company's waste-to-energy project in Oude Tonge, the Netherlands in June 2018 and relatively higher levels of radiation in Italy during 2019 compared to 2018.
  • Operating expenses were approximately €6.6 million for the year ended December 31, 2019, compared to approximately €6.3 million for the year ended December 31, 2018. The increase in operating expenses is mainly attributable to additional operating expenses from the commencement of operations at the Company's waste-to-energy project in Oude Tonge, the Netherlands. Depreciation and amortization expenses were approximately €6.4 million for the year ended December 31, 2019, compared to approximately €5.8 million for the year ended December 31, 2018.
  • Project development costs were approximately €4.2 million for the year ended December 31, 2019, compared to approximately €2.9 million for the year ended December 31, 2018. The increase in project development costs is mainly attributable to consultancy expenses for the planned construction of a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.
  • General and administrative expenses were approximately €3.8 million for the year ended December 31, 2019, compared to approximately €3.6 million for the year ended December 31, 2018 due to a slight increase in labor and consultancy expenses.
  • Share of profits of equity accounted investee, after elimination of intercompany transactions, was approximately €3.1 million in the year ended December 31, 2019, compared to approximately €2.5 million in the year ended December 31, 2018. The increase in the Company's share of profit of equity accounted investee is mainly attributable to an increase in sales of electricity by Dorad and to lower financial expenses incurred by Dorad as a result of the CPI indexation of loans from banks and related parties.
  • Other expenses, net for the year ended December 31, 2019 were approximately €2.1 million, compared to other income, net of approximately €0.9 million in the year ended December 31, 2018. During 2019 the Company recorded expenses in the amount of approximately €2.1 million in connection with the announcement received from Gestore dei Servizi Elettrici ("GSE") Italy's energy regulation agency, by one of the Company's Italian subsidiaries, claiming alleged non-compliance of the installed modules with the required certifications under the applicable regulation and raising the need to examine incentive eligibility implications (the "GSE Claim"). On December 20, 2019, the Company sold its holdings in this subsidiary. The Sale and Purchase Agreement governing the sale of the subsidiary provided for of up to €2.1 million of indemnification in connection with the GSE Claim and the Company recorded this potential payment as other expenses.
  • On December 20, 2019, in connection with the sale of ten Italian indirect wholly-owned subsidiaries of the Company, which own twelve photovoltaic plants with an aggregate nominal capacity of approximately 22.6 MW, the Company recorded a capital gain in the amount of approximately €18.8 million. The agreed purchase price was €41 million for the cutoff date of December 31, 2018 and adjusted in connection with funds received by the Company from the Italian Subsidiaries during 2019 (approximately €2.3 million), resulting in a cash purchase price of approximately €38.7 million.
  • Financing expenses, net was approximately €8.2 million for the year ended December 31, 2019, compared to approximately €2.1 million for the year ended December 31, 2018. The increase in financing expenses was mainly due to: (i) expenses in connection with exchange rate differences amounting to approximately €2 million in the twelve months ended December 31, 2019, mainly in connection with the Company's NIS denominated Debentures, the loan to an equity accounted investee and cash and cash equivalents, caused by the 9.6% devaluation of the euro against the NIS during this period, compared to income in connection with exchange rate differences amounting to approximately €0.7 million in the twelve months ended December 31, 2018 (ii) charges of approximately €2 million recorded in 2019 in connection with the early repayment of the entire outstanding principal of the Company's Series A Debentures, and (iii) an increase of approximately €0.5 million in interest and swap expenses mainly as a result of the financing transaction entered in March 2019 by four Spanish indirect wholly-owned subsidiaries and as a result of expenses recorded in connection with the swap transaction entered by the Italian subsidiaries that were sold on December 20, 2019.
  • Tax benefit was approximately €0.3 million in the year ended December 31, 2019, compared to taxes on income of approximately €0.2 million in the year ended December 31, 2018. The change is due to deferred taxes arising from timing differences in depreciation expenses in connection with the Talasol Project.
  • Net profit was approximately €9.8 million in the year ended December 31, 2019, compared to net loss of approximately €0.6 million for the year ended December 31, 2018.
  • Net profit per share was approximately €1.09 in the year ended December 31, 2019, compared to approximately €0.1 for the year ended December 31, 2018.
  • Total other comprehensive income was approximately €1.3 million for the year ended December 31, 2019, compared to total other comprehensive loss of approximately €1.2 million in the year ended December 31, 2018. The change was mainly due to changes in fair value of cash flow hedges and from foreign currency translation differences on New Israeli Shekel denominated operations, as a result of fluctuations in the euro/NIS exchange rates.
  • Total comprehensive profit was approximately €10.3 million in the year ended December 31, 2019, compared to total comprehensive loss of approximately €0.5 million in the year ended December 31, 2018.
  • EBITDA was approximately €24.1 million for the year ended December 31, 2019 (including €18.8 million capital gain recorded in connection of the sale of Italian subsidiaries), compared to approximately €8.7 million for the year ended December 31, 2018.
  • Net cash from operating activities was approximately €3.7 million for the year ended December 31, 2019, compared to approximately €6.6 million for the year ended December 31, 2018.
  • As of March 1, 2020, the Company held approximately €59.4 million in cash and cash equivalents , approximately €2.2 million in marketable securities and approximately €10.1 million in restricted long-term cash.
  • On March 30, 2020, the Company's Board of Directors approved a plan to repurchase the Company's debentures in an aggregate amount of up to NIS 15 million for a six month period. The timing, volume and nature of repurchases will be at the sole discretion of management and will depend on market conditions, the price and availability of the Company's debentures, and other factors. No assurance can be given that any particular amount of debentures will be repurchased and the repurchase plan does not obligate the Company to acquire a specific amount of debentures in any period.

Ran Fridrich, CEO and a board member of Ellomay, commented: "2019 was marked with substantial accomplishments for Ellomay Capital. The Talasol project reached financial closing and we added two equity partners to the project that acquired 49% of the holdings at a premium. In addition, as of the today, construction is progressing according to the business plan. We acquired the minority holdings in the Netherlands biogas projects and as of today the results of such projects are in line with the business plan objectives. Further improvements are planned for implementation in the near future and we expect that these improvements will improve the results beyond the basic business plan.

The Company sold its yielding PV assets portfolio in Italy, generating a capital gain from the sale of approximately €19 million.

We obtained long-term project financing for the PV yielding assets in Spain under good terms while generating value to such assets.

We completed an early repayment of our Series A debentures (in the amount approximately NIS 80 million).

In addition, the Company entered into agreements for the development of new PV projects in Italy and Spain of approximately 550 MW and as of today the development process is progressing as planned.

The year ended with a profit attributable to the Company's owners of approximately €12 million. Shareholders' equity attributed to Company owners increased by approximately €28 million. Such equity will enable the Company to enter the challenging period ahead in the best possible way. We are following the global events and the impact of COVID-19 on the economy and specifically on the Company's operations. We cannot at this point assess whether and how the Company's operations and assets will be impacted by the crisis."

Use of NON-IFRS Financial Measures

EBITDA is a non-IFRS measure and is defined as earnings before financial expenses, net, taxes, depreciation and amortization. The Company presents this measure in order to enhance the understanding of the Company's historical financial performance and to enable comparability between periods. While the Company considers EBITDA to be an important measure of comparative operating performance, EBITDA should not be considered in isolation or as a substitute for net income or other statement of operations or cash flow data prepared in accordance with IFRS as a measure of profitability or liquidity. EBITDA does not take into account the Company's commitments, including capital expenditures, and restricted cash and, accordingly, is not necessarily indicative of amounts that may be available for discretionary uses. Not all companies calculate EBITDA in the same manner, and the measure as presented may not be comparable to similarly-titled measures presented by other companies. The Company's EBITDA may not be indicative of the historic operating results of the Company; nor is it meant to be predictive of potential future results. A reconciliation between results on an IFRS and non-IFRS basis is provided in the last table of this press release.

About Ellomay Capital Ltd.

Ellomay is an Israeli based company whose shares are registered with the NYSE American and with the Tel Aviv Stock Exchange under the trading symbol "ELLO". Since 2009, Ellomay Capital focuses its business in the renewable energy and power sectors in Europe and Israel.

To date, Ellomay has evaluated numerous opportunities and invested significant funds in the renewable, clean energy and natural resources industries in Israel, Italy and Spain, including:

  • Approximately 7.9MW of photovoltaic power plants in Spain and a photovoltaic power plant of approximately 9 MW in Israel;
  • 9.375% indirect interest in Dorad Energy Ltd., which owns and operates one of Israel's largest private power plants with production capacity of approximately 850MW, representing about 6%-8% of Israel's total current electricity consumption;
  • 51% of Talasol, which is involved in a project to construct a photovoltaic plant with a peak capacity of 300MW in the municipality of Talaván, Cáceres, Spain;
  • 100% of Groen Gas Goor B.V. and of Groen Gas Oude-Tonge B.V., project companies developing anaerobic digestion plants with a green gas production capacity of approximately 375 Nm3/h, in Goor, the Netherlands and 475 Nm3/h, in Oude Tonge, the Netherlands, respectively;
  • 75% of Ellomay Pumped Storage (2014) Ltd. (including 6.67% that are held by a trustee in trust for us and other parties), which is involved in a project to construct a 156 MW pumped storage hydro power plant in the Manara Cliff, Israel.

Ellomay Capital is controlled by Mr. Shlomo Nehama, Mr. Hemi Raphael and Mr. Ran Fridrich. Mr. Nehama is one of Israel's prominent businessmen and the former Chairman of Israel's leading bank, Bank Hapohalim, and Messrs. Raphael and Fridrich both have vast experience in financial and industrial businesses. These controlling shareholders, along with Ellomay's dedicated professional management, accumulated extensive experience in recognizing suitable business opportunities worldwide. Ellomay believes the expertise of Ellomay's controlling shareholders and management enables the Company to access the capital markets, as well as assemble global institutional investors and other potential partners. As a result, we believe Ellomay is capable of considering significant and complex transactions, beyond its immediate financial resources.

For more information about Ellomay, visit http://www.ellomay.com.

Information Relating to Forward-Looking Statements

This press release contains forward-looking statements that involve substantial risks and uncertainties, including statements that are based on the current expectations and assumptions of the Company's management. All statements, other than statements of historical facts, included in this press release regarding the Company's plans and objectives, expectations and assumptions of management are forward-looking statements.  The use of certain words, including the words "estimate," "project," "intend," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The Company may not actually achieve the plans, intentions or expectations disclosed in the forward-looking statements and you should not place undue reliance on the Company's forward-looking statements. Various important factors could cause actual results or events to differ materially from those that may be expressed or implied by the Company's forward-looking statements, including the impact of COVID-19 virus on the Company's operations and projects, including in connection with steps taken by authorities in countries in which the Company operates, regulatory changes, changes in the supply and prices of resources required for the operation of the Company's facilities (such as waste and natural gas) and in the price of oil, changes in demand and technical and other disruptions in the operations or construction of the power plants owned by the Company in addition to other risks and uncertainties associated with the Company's business that are described in greater detail in the filings the Company makes from time to time with Securities and Exchange Commission, including its Annual Report on Form 20-F. The forward-looking statements are made as of this date and the Company does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Financial Position



December 31,


2019

2018

2019


Unaudited

Audited

Unaudited


€ in thousands

Convenience Translation into
US$ in thousands*
*

Assets


Current assets:


Cash and cash equivalents

44,509

36,882

49,946

Marketable securities

2,242

2,132

2,516

Short term deposits

6,446

-

7,233

Restricted cash

22,162

  (*) 1,315

24,869

Receivable from concession project

1,463

1,292

1,642

Financial assets

1,418

1,282

1,591

Trade and other receivables

4,882

12,623

5,478


83,122

55,526

93,275

Non-current assets


Investment in equity accounted investee

33,561

27,746

37,661

Advances on account of investments

883

798

991

Receivable from concession project

27,122

25,710

30,435

Fixed assets

126,607

87,220

142,074

Right-of-use asset

15,401

-

17,282

Intangible asset

5,042

4,882

5,658

Restricted cash and deposits

10,956

 (*) 5,400

12,294

Deferred tax

2,285

2,423

2,564

Long term receivables

31

1,455

35

Derivatives

5,162

-

5,793


227,050

155,634

254,787





Total assets

310,172

211,160

348,062



Liabilities and Equity


Current liabilities


Current maturities of long term loans

4,138

5,864

4,644

Debentures

26,773

8,758

30,044

Trade payables

1,765

2,126

1,979

Other payables

5,010

3,103

5,622


37,686

19,851

42,289

Non-current liabilities




Lease liability

15,402

-

17,284

Long-term loans

89,182

60,228

100,077

Debentures

44,811

42,585

50,285

Deferred tax

6,467

6,219

7,257

Other long-term liabilities

1,795

(*) 1,959

2,014

Derivatives

7,263

 (*) 3,361

8,150


164,920

114,352

185,067

Total liabilities

202,606

134,203

227,356

Equity


Share capital

21,998

19,980

24,685

Share premium

64,160

58,344

71,998

Treasury shares

(1,736)

(1,736)

(1,948)

Transaction reserve with non-controlling Interests

6,106

-

6,852

Reserves

3,283

1,169

3,684

Retained earnings

12,818

758

14,384

Total equity attributed to shareholders ofthe Company

106,629

78,515

119,655

Non-Controlling Interest

937

(1,558)

1,051

Total equity

107,566

76,957

120,706

Total liabilities and equity

310,172

211,160

348,062

* Reclassified (Reclassification of €3,338 thousand deposit from short-term to long-term restricted cash and deposits to reflect more appropriately the nature and the commitments such deposit is intended to secure)
** Convenience translation into US$ (exchange rate as at December 31, 2019: euro 1 = US$ 1.122)

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Financial Position



For the three months ended December 31,

For the year

ended December 31,

For the three
months ended December 31,

For the year
ended December 31,



2018

2019

2018

2019

2019

2019


Unaudited

Audited

Unaudited

Unaudited


€ in thousands

Convenience Translation into US$*

Revenues

4,246

3,553

18,117

18,988

3,987

21,308

Operating expenses

(1,769)

(1,589)

(6,342)

(6,638)

(1,783)

(7,449)

Depreciation and amortization

(1,452)

(1,702)

(5,816)

(6,416)

(1,910)

(7,200)

Gross profit

1,025

262

5,959

5,934

294

6,659








Project development costs

(256)

(742)

(2,878)

(4,213)

(833)

(4,728)

General and administrative expenses

(838)

(969)

(3,600)

(3,827)

(1,087)

(4,295)

Share of profits of equity accounted investee

331

704

2,545

3,086

790

3,463

Other income (expenses), net

811

(2,100)

884

(2,100)

(2,357)

(2,357)

Capital gain

-

18,770

-

18,770

21,063

21,063

Operating profit

1,073

15,925

2,910

17,650

17,870

19,805








Financing income

739

385

2,936

1,827

432

2,050

Financing income (expenses) in connection with derivatives, net

347

(98)

494

897

(110)

1,007

Financing expenses

(1,342)

(3,828)

(5,521)

(10,877)

(4,296)

(12,206)

Financing expenses, net

(256)

(3,541)

(2,091)

(8,153)

(3,974)

(9,149)

Profit before taxes on income

817

12,384

819

9,497

13,897

10,656

Tax benefit (Taxes on income)

(95)

1,200

(215)

287

1,347

322

Profit for the period

722

13,584

604

9,784

15,243

10,978

Profit (loss) attributable to:







Owners of the Company

673

13,683

1,057

12,060

15,355

13,533

Non-controlling interests

49

(99)

(453)

(2,276)

(111)

(2,555)

Profit for the  period

722

13,584

604

9,784

15,243

10,978

Other comprehensive income (loss) items that after







initial recognition in comprehensive income (loss)







were or will be transferred to profit or loss:







Foreign currency translation differences for foreign operations

(258)

(7,008)

(787)

2,103

(7,864)

 

2,360

Other comprehensive income items that will not be transferred to profit or loss:







Effective portion of change in fair value of cash flow hedges

(476)

(5,901)

(1,008)

1,076

(6,622)

1,207

Net change in fair value of cash flow hedges transferred to profit or loss

348

356

643

(1,922)

399

(2,157)

Total other comprehensive profit (loss)

(386)

(12,553)

(1,152)

1,257

(14,087)

1,410

Total comprehensive profit (loss) for the period

336

1,031

(548)

11,041

1,157

12,388








Basic net profit per share

0.06

1.19

0.10

1.09

1.36

1.24

Diluted net profit per share

0.06

1.19

0.10

1.09

1.36

1.24

  

* Convenience translation into US$ (exchange rate as at December 31, 2019: euro 1 = US$ 1.122)

 

 

Ellomay Capital Ltd. and its Subsidiaries

Condensed Consolidated Statements of Changes in Equity (in thousands)



Attributable to shareholders of the Company

Non- controlling

Total




Interests

Equity













 

 

 

Share capital

 

 

 

Share premium

 

 

 

Retained earnings

 

 

 

Treasury shares

 

Translation reserve from foreign operations

 

 

 

Hedging Reserve

Interests Transaction reserve with non-controlling Interests

 

 

 



There is no comments yet.

You must login Login Sign up

Testimonials

  • To share with you this wonderful experience full of colour and natural beauty makes my life full of sense. With your family, partner or friends, I will make this trip unique and unmatched.
    I love elephants and leopards - I use Safari, as my preferred internet browser, on my Mac computer.
    Cristopher - Tanzania safari guide
  • Having breakfast in Santorini and buying jewellery in Mykonos are two of my greatest pleasures ... Mediterranean islands are crown jewels.
    Catalina - Accounting aboard a Mediterranean cruise ship
  • Dance, dance and dance ... I can not think of a life without music, joy and dancing ... I always go after work to see my friends and we dance together to the best songs of the Caribbean.
    Israel - In charge of a warehouse and shop manager of a holiday club in the Havana Cuba